{"id":"W2589103622","doi":"10.1016/j.cllc.2017.02.001","title":"Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Clinical Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Atezolizumab; Pemetrexed; Nivolumab; Internal medicine; Oncology; Erlotinib; Lung cancer; Hazard ratio; Docetaxel; Adverse effect; Gefitinib; Chemotherapy; Erlotinib Hydrochloride; Epidermal growth factor receptor; Cancer; Immunotherapy; Confidence interval; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00174685,0.00118098,0.00580715,0.002853981,0.0002595636,0.001315959,0.001198425,0.001368672,0.004338908],"category_scores_gemma":[0.005649018,0.0006444121,0.006743313,0.002950522,0.0003834171,0.001155442,0.001025845,0.001200272,0.0002473762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00126759,"about_ca_system_score_gemma":0.002791517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003874301,"about_ca_topic_score_gemma":0.01763436,"domain_scores_codex":[0.9988721,0.000294294,0.0004306138,0.0001533613,0.0001776306,0.00007204312],"domain_scores_gemma":[0.9976,0.00138381,0.0007520465,0.00003127028,0.0001737396,0.00005911953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0009202708,0.00004526931,0.0013927,0.8771361,0.03320422,0.0001215885,0.0001061965,0.000276907,0.0004546476,0.0002134087,0.004805969,0.08132276],"study_design_scores_gemma":[0.00280365,0.0008676727,0.01017005,0.4978805,0.4176446,0.0008092846,0.0003188798,0.0002283443,0.000418386,0.0005783514,0.06817421,0.0001062067],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004339906,0.9991037,0.00003246678,0.00009055161,0.000055873,0.00004082851,0.0001329179,0.000003000813,0.0001066029],"genre_scores_gemma":[0.01038127,0.9884786,0.0001916736,0.0006102227,0.00006050347,0.00006493391,0.0001180669,0.000001893277,0.00009277336],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00580715,"threshold_uncertainty_score":0.01451516,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0542220111495793,"score_gpt":0.4328983314420488,"score_spread":0.3786763202924694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}